NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
Voltar para busca
Dado oficial do USPTO
HIPRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
09/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
28/01/2022
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2021-00-00
Primeiro uso no comércio
23/07/2024
Código do desenho
3
Tipo de titular
99
Localização do titular
AMER (GIRONA), ES
Examinador
MAGIT, JACOB FLEMING
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "HIPRA" in white inside a blue rectangle.
Titulares e representantes
Titulares
LABORATORIOS HIPRA, S.A.
Representantes
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productsbiological vaccines for human and veterinary use; biological preparations for medical and veterinary useveterinary vaccines; veterinary preparations for the treatment of intestinal bacteria; anti- infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substancesvaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary usereagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary usereagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparationsvaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccines
Classe 42
Scientific and technological servicesas well as associated research and design servicesscientific researchanalysis and testing in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevicesinstruments; industrial analysis and research services in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevicesinstrumentsas well as of computer software related to the biomedical and pharmaceutical sectorindustrial design services; quality control services for others in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevices and instruments; design and development of computer hardware and software; research and development of vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmaceuticals; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industriesinformation technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development; services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment; research and development of vaccines and medicines; biological research and analysis; development of computer software in the pharmaceuticalmedicalveterinarysanitary and diagnostic field; clinical research in the field of veterinary preparationsbiotherapeutic medicinesantibodies; blood testing services for scientific research; scientific analysis services relating to the assessment of bacteria content in liquids
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/11/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/10/2025
IUAF
USE AMENDMENT FILED
18/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
18/06/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX2G
SOU EXTENSION 2 GRANTED
19/12/2024
EXT2
SOU EXTENSION 2 FILED
19/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
19/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/06/2024
EX1G
SOU EXTENSION 1 GRANTED
20/06/2024
EXT1
SOU EXTENSION 1 FILED
20/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
20/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2023
PUBO
PUBLISHED FOR OPPOSITION
24/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
18/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
18/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/09/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/06/2023
GNFR
FINAL REFUSAL E-MAILED
12/06/2023
CNFR
FINAL REFUSAL WRITTEN
12/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/11/2022
GNRT
NON-FINAL ACTION E-MAILED
23/11/2022
CNRT
NON-FINAL ACTION WRITTEN
23/11/2022
DOCK
ASSIGNED TO EXAMINER
09/11/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
24/02/2022
ALIE
ASSIGNED TO LIE
24/02/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
18/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2022
NWAP
NEW APPLICATION ENTERED
01/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HIPRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.